{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:31:53Z","timestamp":1787070713754,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The \u201cGabrin sign\u201d has been named after Dr Frank Gabrin, who was the first American physician to succumb to the novel coronavirus disease 2019 (COVID-19). The physician also suffered from androgenetic alopecia (AGA), thence came the eponymous sign. It has been widely postulated that the androgen pathway is a contributing factor in COVID-19 disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>This case\u2013control study was aimed at assessing the prevalence of AGA in patients admitted to the intensive care unit due to severe COVID-19 from three tertiary care centers in Rajasthan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>During the overwhelming surge of cases between March 2021 and August 2021, the investigators randomly examined patients for the presence of AGA. AGA severity was assessed by the Hamilton\u2013Norwood Scale and Ludwig Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study included 379 cases of AGA with confirmed COVID-19 infection admitted in COVID-19 dedicated wards and 379 age- and sex-matched controls without AGA from the same wards. The male-to-female ratio was 3.9:1. The disease severity of COVID-19 was significantly higher in cases than controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001). Cases with severe AGA had a significantly higher proportion of COVID-19 severity (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our study provides preliminary evidence that COVID-19 severity could be androgen-mediated. However, this hypothesis requires further validation. In addition, antiandrogen treatments such as spironolactone, degarelix, and bicalutamide could theoretically be investigated in the management or prophylaxis of COVID-19 severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijt.ijt_5_23","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:00:20Z","timestamp":1750690820000},"page":"54-57","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Role of the Gabrin Sign in Predicting COVID-19 Severity Among Patients with Androgenic Alopecia"],"prefix":"10.4103","volume":"17","author":[{"given":"Alpana","family":"Mohta","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Sardar Patel Medical College, Bikaner, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiti","family":"Pareek","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Sardar Patel Medical College, Bikaner, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Nyati","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Government Medical College, Kota, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijeta","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Government Medical College, Kota, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Jhalawar Medical College, Jhalawar, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhikam Chand","family":"Ghiya","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Sardar Patel Medical College, Bikaner, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"R2-20250628","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/jcm9040941","article-title":"Novel coronavirus infection (COVID-19) in humans:A scoping review and meta-analysis","volume":"9","author":"Borges do Nascimento","year":"2020","journal-title":"J Clin Med"},{"key":"R3-20250628","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40618-020-01383-6","article-title":"Gender susceptibility to COVID-19:A review of the putative role of sex hormones and X chromosome","volume":"44","author":"Foresta","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"R4-20250628","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3390\/cancers12082325","article-title":"Sex hormones and hormone therapy during COVID-19 pandemic:Implications for patients with cancer","volume":"12","author":"Cattrini","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R5-20250628","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijwd.2020.04.012","article-title":"Evaluation of the efficacy and safety of cow placenta extract lotion versus minoxidil 2% in the treatment of female pattern androgenetic alopecia","volume":"6","author":"Barat","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"R6-20250628","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaad.2020.05.079","article-title":"Androgenetic alopecia present in the majority of patients hospitalized with COVID-19:The \u201cGabrin sign\u201d","volume":"83","author":"Wambier","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R7-20250628","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11845-022-02981-4","article-title":"Association of androgenetic alopecia with a more severe form of COVID-19 infection","volume":"192","author":"Veskovic","year":"2023","journal-title":"Ir J Med Sci"},{"key":"R8-20250628","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/j.jaad.2020.07.099","article-title":"Androgenetic alopecia in COVID-19:Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign","volume":"83","author":"Wambier","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R9-20250628","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0974-7753.58556","article-title":"Male androgenetic alopecia:Population-based study in 1,005 subjects","volume":"1","author":"Krupa Shankar","year":"2009","journal-title":"Int J Trichology"},{"key":"R10-20250628","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","article-title":"Male pattern baldness:Classification and incidence","volume":"68","author":"Norwood","year":"1975","journal-title":"South Med J"},{"key":"R11-20250628","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1111\/jdv.17004","article-title":"Clinical symptoms of hyperandrogenic women diagnosed with COVID-19","volume":"35","author":"Cadegiani","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R12-20250628","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1530\/EJE-20-1163","article-title":"Increased COVID-19 infections in women with polycystic ovary syndrome:A population-based study","volume":"184","author":"Subramanian","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"R13-20250628","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jocd.13443","article-title":"Apreliminary observation:Male pattern hair loss among hospitalized COVID-19 patients in Spain \u2013A potential clue to the role of androgens in COVID-19 severity","volume":"19","author":"Goren","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"R14-20250628","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/0019-5154.160507","article-title":"Study of the international epidemiology of androgenetic alopecia in young Caucasian men using photographs from the Internet","volume":"60","author":"Avital","year":"2015","journal-title":"Indian J Dermatol"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_5_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:35:17Z","timestamp":1787067317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_5_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_5_23","relation":{},"ISSN":["0974-7753","0974-9241"],"issn-type":[{"value":"0974-7753","type":"print"},{"value":"0974-9241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2023-01-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}